EG666713 inhibitors are a class of chemical compounds that target the EG666713 protein, which is involved in various cellular processes. These inhibitors work by selectively binding to EG666713, thereby modulating its activity and affecting downstream signaling pathways. The structure of EG666713 inhibitors is characterized by a core scaffold that allows for specific interaction with the target protein, often involving aromatic rings, heterocyclic components, and functional groups that enhance binding affinity. This binding typically interferes with the enzymatic or regulatory function of EG666713, leading to alterations in cellular functions such as signal transduction, transcription, or other biochemical pathways. The molecular design of EG666713 inhibitors is often highly specific to optimize potency and selectivity while minimizing interactions with non-target proteins, thereby reducing off-target effects and increasing efficacy in modulating the activity of EG666713.
The chemical properties of EG666713 inhibitors, such as solubility, stability, and cell permeability, are key factors that contribute to their bioavailability and effectiveness in biological systems. These inhibitors can vary widely in their chemical nature, ranging from small molecules to larger, more complex structures, but they generally share common features that promote strong and specific binding to EG666713. Chemical modifications to the core scaffold and side chains are often employed to enhance these properties, tailoring the compounds to achieve the desired balance of potency, selectivity, and pharmacokinetic profile. Additionally, structural-activity relationship (SAR) studies are conducted to identify optimal chemical groups and configurations that enhance the interaction between the inhibitor and EG666713. By fine-tuning the chemical structure, researchers aim to produce inhibitors that are not only effective in modulating EG666713 activity but also suitable for further biological research and exploration.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Binds to actin monomers, preventing polymerization and potentially disrupting cytoskeletal interactions. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds tubulin, inhibiting its polymerization, potentially impacting cell division and intracellular transport. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, affecting cell division and intracellular dynamics, which may alter CCDC168-related processes. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules, which can interfere with cell division and vesicle transport systems. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, affecting signal transduction pathways linked to various cellular processes that CCDC168 may be a part of. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may impact signal transduction pathways involving CCDC168. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibitor of ROCK kinase, affecting cell shape, motility, and potentially protein-protein interactions. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Inhibits myosin II, affecting cell motility and cytokinesis, which could influence CCDC168's role in these processes. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase, affecting cell contraction and motility. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, which could alter signal transduction pathways related to CCDC168. | ||||||